State Street’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

State Street’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-568,559	Closed	-$23.5M	–	3768
2015 Q2	$23.5M	Buy	568,559 +2,133	+0.4%	+$76.5K	﹤0.01%	1755
2015 Q1	$20M	Buy	566,426 +39,007	+7%	+$1.32M	﹤0.01%	1848
2014 Q4	$16.9M	Buy	527,419 +10,120	+2%	+$293K	﹤0.01%	1912
2014 Q3	$14.5M	Sell	517,299 -3,496	-0.7%	-$106K	﹤0.01%	1957
2014 Q2	$15.7M	Sell	520,795 -18,970	-4%	-$524K	﹤0.01%	1972
2014 Q1	$14.9M	Buy	539,765 +13,104	+2%	+$343K	﹤0.01%	1970
2013 Q4	$13.4M	Sell	526,661 -4,244	-0.8%	-$131K	﹤0.01%	2022
2013 Q3	$15.9M	Buy	530,905 +9,340	+2%	+$260K	﹤0.01%	1838
2013 Q2	$15M	Buy	+521,565	New	+$14.4M	﹤0.01%	1810

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

State Street's BRLI Position: Q3 2015 in Review

State Street sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 568,559 shares — an estimated $23.5M sold.

State Street first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $23.5M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

State Street reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
State Street sold 568,559 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $23.5M.
State Street first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
State Street's BIO-REFERENCE LABS INC-NEW- position peaked at $23.5M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on State Street's 13F filing for Q3 2015, filed 16 Nov 2015.